The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Abadole     1,3-thiazol-2-amine

Synonyms: Basedoe, Basedol, Abadol, Aminotiazol, Aminothiazol, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of aminothiazole


Psychiatry related information on aminothiazole


High impact information on aminothiazole


Chemical compound and disease context of aminothiazole


Biological context of aminothiazole


Anatomical context of aminothiazole


Associations of aminothiazole with other chemical compounds


Gene context of aminothiazole


Analytical, diagnostic and therapeutic context of aminothiazole


  1. Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability. Bressolle, F., de la Coussaye, J.E., Ayoub, R., Fabre, D., Gomeni, R., Saissi, G., Eledjam, J.J., Galtier, M. Antimicrob. Agents Chemother. (1992) [Pubmed]
  2. In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum. Conrad, D.A., Scribner, R.K., Weber, A.H., Marks, M.I. Antimicrob. Agents Chemother. (1985) [Pubmed]
  3. Ureas of 5-aminopyrazole and 2-aminothiazole inhibit growth of gram-positive bacteria. Kane, J.L., Hirth, B.H., Liang, B., Gourlie, B.B., Nahill, S., Barsomian, G. Bioorg. Med. Chem. Lett. (2003) [Pubmed]
  4. A randomised double blind trial comparing the treatment of episcleritis with topical 2-(2-Hydroxy-4-methylphenyl) Aminothiazole Hydrochloride 0.1% (CBS 113A) and placebo. Liu, C.S., Ramirez-Florez, S., Watson, P.G. Eye (London, England) (1991) [Pubmed]
  5. Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's disease. Helal, C.J., Sanner, M.A., Cooper, C.B., Gant, T., Adam, M., Lucas, J.C., Kang, Z., Kupchinsky, S., Ahlijanian, M.K., Tate, B., Menniti, F.S., Kelly, K., Peterson, M. Bioorg. Med. Chem. Lett. (2004) [Pubmed]
  6. Characterization of endothelial nitric-oxide synthase and its reaction with ligand by electron paramagnetic resonance spectroscopy. Tsai, A.L., Berka, V., Chen, P.F., Palmer, G. J. Biol. Chem. (1996) [Pubmed]
  7. 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. Das, J., Chen, P., Norris, D., Padmanabha, R., Lin, J., Moquin, R.V., Shen, Z., Cook, L.S., Doweyko, A.M., Pitt, S., Pang, S., Shen, D.R., Fang, Q., de Fex, H.F., McIntyre, K.W., Shuster, D.J., Gillooly, K.M., Behnia, K., Schieven, G.L., Wityak, J., Barrish, J.C. J. Med. Chem. (2006) [Pubmed]
  8. Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2. Borzilleri, R.M., Bhide, R.S., Barrish, J.C., D'Arienzo, C.J., Derbin, G.M., Fargnoli, J., Hunt, J.T., Jeyaseelan, R., Kamath, A., Kukral, D.W., Marathe, P., Mortillo, S., Qian, L., Tokarski, J.S., Wautlet, B.S., Zheng, X., Lombardo, L.J. J. Med. Chem. (2006) [Pubmed]
  9. Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities. Kim, K.S., Kimball, S.D., Misra, R.N., Rawlins, D.B., Hunt, J.T., Xiao, H.Y., Lu, S., Qian, L., Han, W.C., Shan, W., Mitt, T., Cai, Z.W., Poss, M.A., Zhu, H., Sack, J.S., Tokarski, J.S., Chang, C.Y., Pavletich, N., Kamath, A., Humphreys, W.G., Marathe, P., Bursuker, I., Kellar, K.A., Roongta, U., Batorsky, R., Mulheron, J.G., Bol, D., Fairchild, C.R., Lee, F.Y., Webster, K.R. J. Med. Chem. (2002) [Pubmed]
  10. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Sowek, J.A., Singer, S.B., Ohringer, S., Malley, M.F., Dougherty, T.J., Gougoutas, J.Z., Bush, K. Biochemistry (1991) [Pubmed]
  11. Role of an aminothiazole derivative on ethanol- and thermally oxidized sunflower oil-induced toxicity. Aruna, K., Rukkumani, R., Sureshvarma, P., Menon, V.P. Polish journal of pharmacology. (2004) [Pubmed]
  12. Studies on the anti-inflammatory activity and ulcerogenic adverse effect of thiazole derivatives, especially 2-amino-thiazoleacetic acid derivatives. Nagatomi, H., Ando, K. Arzneimittel-Forschung. (1984) [Pubmed]
  13. Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors. Vulpetti, A., Casale, E., Roletto, F., Amici, R., Villa, M., Pevarello, P. J. Mol. Graph. Model. (2006) [Pubmed]
  14. Hemostasis in patients with normal and impaired renal function under treatment with cefodizime. Andrassy, K., Koderisch, J., Trenk, D., Jähnchen, E., Iwand, A. Infection (1987) [Pubmed]
  15. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli. Tuomanen, E., Gilbert, K., Tomasz, A. Antimicrob. Agents Chemother. (1986) [Pubmed]
  16. Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors. Das, J., Liu, C., Moquin, R.V., Lin, J., Furch, J.A., Spergel, S.H., McIntyre, K.W., Shuster, D.J., O'Day, K.D., Penhallow, B., Hung, C.Y., Kanner, S.B., Lin, T.A., Dodd, J.H., Barrish, J.C., Wityak, J. Bioorg. Med. Chem. Lett. (2006) [Pubmed]
  17. The immunomodulatory effects of antibiotics: in vitro and ex vivo investigations of 21 substances by means of the lymphocyte transformation test. Schubert, S., Andresen, B.H., Bähr, V., Fischer, L., Stamp, R., Stricker, G., Wittke, J.W., Ullmann, U. Zentralbl. Bakteriol. (1996) [Pubmed]
  18. Interaction of metronidazole with antibiotics containing the 2-aminothiazole moiety. Thakur, A.B., Abdelnasser, M., Serajuddin, A.T., Wadke, D.A. Pharm. Res. (1991) [Pubmed]
  19. Structure-activity relationships of 2-aminothiazole derivatives as inducible nitric oxide synthase inhibitor. Ueda, S., Terauchi, H., Kawasaki, M., Yano, A., Ido, M. Chem. Pharm. Bull. (2004) [Pubmed]
  20. Optimization of 2-aminothiazole derivatives as CCR4 antagonists. Wang, X., Xu, F., Xu, Q., Mahmud, H., Houze, J., Zhu, L., Akerman, M., Tonn, G., Tang, L., McMaster, B.E., Dairaghi, D.J., Schall, T.J., Collins, T.L., Medina, J.C. Bioorg. Med. Chem. Lett. (2006) [Pubmed]
  21. Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors. Das, J., Furch, J.A., Liu, C., Moquin, R.V., Lin, J., Spergel, S.H., McIntyre, K.W., Shuster, D.J., O'Day, K.D., Penhallow, B., Hung, C.Y., Doweyko, A.M., Kamath, A., Zhang, H., Marathe, P., Kanner, S.B., Lin, T.A., Dodd, J.H., Barrish, J.C., Wityak, J. Bioorg. Med. Chem. Lett. (2006) [Pubmed]
  22. Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases. Wipf, P., Aslan, D.C., Southwick, E.C., Lazo, J.S. Bioorg. Med. Chem. Lett. (2001) [Pubmed]
  23. Introduction of novel substrate oxidation into cytochrome c peroxidase by cavity complementation: oxidation of 2-aminothiazole and covalent modification of the enzyme. Musah, R.A., Goodin, D.B. Biochemistry (1997) [Pubmed]
WikiGenes - Universities